Recognizing that the challenges facing Taiwan’s pharmaceutical market are inextricably linked to the structure and soundess of the overall healthcare system, the board of the International Reasearch-based Pharmaceutical Manufacturers Association (IRPMA) last year decided to prepare a comprehensive set of recommendations for shaping the next generation of Taiwan’s healthcare. The Association commissioned consultancy PwC Taiwan…

“Robust intellectual property (IP) protection is vital for biopharmaceutical innovation,” stresses a recently released report from Geneva Network, a UK-based public policy research and advocacy organization specializing in international intellectual property, health, and trade issues. The report – written by Geneva Network researcher Jack Ellis, a former Asia-Pacific editor of Intellectual Asset Management magazine –…